Spondin2 is a new prognostic biomarker for lung adenocarcinoma.

about

Spondin2 is a new prognostic biomarker for lung adenocarcinoma.

Item

http://www.wikidata.org/entity/Q41708830

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Spondin2 is a new prognostic biomarker for lung adenocarcinoma.

@en

type

Item

label

Spondin2 is a new prognostic biomarker for lung adenocarcinoma.

@en

prefLabel

Spondin2 is a new prognostic biomarker for lung adenocarcinoma.

@en

P1476

Spondin2 is a new prognostic biomarker for lung adenocarcinoma.

@en

P2093

Honggang Ke

http://www.w3.org/2001/XMLSchema#string

Jia Feng

http://www.w3.org/2001/XMLSchema#string

Jian Liu

http://www.w3.org/2001/XMLSchema#string

Jianguo Zhang

http://www.w3.org/2001/XMLSchema#string

Li Qian

http://www.w3.org/2001/XMLSchema#string

Qing Zhang

http://www.w3.org/2001/XMLSchema#string

Tingting Bian

http://www.w3.org/2001/XMLSchema#string

Xiaoli Li

http://www.w3.org/2001/XMLSchema#string

Xiaopeng Yuan

http://www.w3.org/2001/XMLSchema#string

Yifei Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display

The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment

New molecularly targeted therapies for lung cancer

Gefitinib in the treatment of nonsmall cell lung cancer with activating epidermal growth factor receptor mutation

Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis

Mindin: a novel marker for podocyte injury in diabetic nephropathy.

Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study

Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients

Pathologic correlation of serum carcinoembryonic antigen and cytokeratin 19 fragment in resected nonsmall cell lung cancer.

Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia.

P304

59324-59332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.19577

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28938639

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5601735

http://www.w3.org/2001/XMLSchema#string